Search
Displaying Results For:
Apr 30, 2026
Autoimmune Drugs May Prolong COVID Viral Signals
A new study suggests that people with systemic autoimmune rheumatic diseases (SARDs) may retain pieces of the COVID-19 virus in their bodies for longer periods after infection, particularly if they are taking immunosuppressive medications. Researchers found that 40% of patients with autoimmune rheumatic diseases still had detectable SARS-CoV-2 antigens in their blood three months after […]
- Antibodies
- Autoimmune Diseases
- Infections
- Long COVID
- Research Studies
Apr 16, 2026
What New Research Reveals About Long COVID
New studies suggest Long COVID may be driven by persistent inflammation and immune disruption, helping explain why symptoms can last months or even years after infection.
- Infections
- Long COVID
- Research Studies
Mar 24, 2026
Long COVID Symptoms Linked to Autoantibodies
A new study published in Cell Reports Medicine provides some of the strongest evidence to date that antibodies may play a direct role in Long COVID symptoms. Researchers found that immunoglobulin G (IgG) antibodies taken from Long COVID patients caused persistent pain-like sensitivity when transferred into mice, suggesting these antibodies may actively contribute to the condition rather […]
- Antibodies
- Infections
- Long COVID
- Research Studies
Mar 09, 2026
Long COVID Immune Dysfunction Linked to NK Cells
A study published in Frontiers in Immunology found that long COVID is associated with significant dysfunction of Natural Killer (NK) cells, key components of the innate immune system that identify and eliminate infected or abnormal cells. Researchers observed that individuals with long COVID had both reduced NK cell numbers and signs of functional exhaustion, suggesting these […]
- Infections
- Long COVID
- Research Studies
Feb 16, 2026
NIH RECOVER 2026 Publications: Long Covid Research Updates
New NIH RECOVER studies published in early 2026 highlight emerging findings on long COVID biology, immune dysfunction, and ongoing research aimed at improving diagnosis and treatment.
- Clinical Trials
- Infections
- Long COVID
- Research Studies
Feb 09, 2026
Long COVID Treatment Trials: 2026 RECOVER Update
The NIH RECOVER initiative released new updates on clinical trials investigating treatments for long COVID, including therapies targeting inflammation, immune dysfunction, and viral persistence.
- Clinical Trials
- Long COVID
- Research Studies
- Treatments
Feb 02, 2026
Can a Pacing App Prevent Long COVID Crashes? Trial Results
A six-month randomized controlled trial tested whether a digital pacing platform combined with a wearable activity tracker could reduce post-exertional malaise, or PEM, in adults with long COVID. Quick Definition What Is a Long COVID Crash? A “long COVID crash” refers to post-exertional malaise (PEM), a worsening of symptoms after physical or mental effort. Unlike […]
- Clinical Trials
- Long COVID
- ME/CFS
- Research Studies
- Treatments
Jan 19, 2026
More Evidence Linking COVID-19 and Thyroid Disease
A new 4.5-year observational study published in The Journal of Clinical Endocrinology & Metabolism found that SARS-CoV-2 infection is associated with a significantly increased risk of developing new-onset thyroid disease, even in people who were not hospitalized. Researchers from Montefiore Health System analyzed electronic health records from patients without prior thyroid disease. The study included 15,372 individuals […]
- Infections
- Research Studies
- Thyroid disease